156 related articles for article (PubMed ID: 21380793)
1. Oral docosapentaenoic acid (22:5n-3) is differentially incorporated into phospholipid pools and differentially metabolized to eicosapentaenoic acid in tissues from young rats.
Holub BJ; Swidinsky P; Park E
Lipids; 2011 May; 46(5):399-407. PubMed ID: 21380793
[TBL] [Abstract][Full Text] [Related]
2. Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart.
Murphy MG; Wright V; Ackman RG; Horackova M
Mol Cell Biochem; 1997 Dec; 177(1-2):257-69. PubMed ID: 9450671
[TBL] [Abstract][Full Text] [Related]
3. Differential accumulation and release of long-chain n-3 fatty acids from liver, muscle, and adipose tissue triacylglycerols.
Herzberg GR; Skinner C
Can J Physiol Pharmacol; 1997 Aug; 75(8):945-51. PubMed ID: 9360007
[TBL] [Abstract][Full Text] [Related]
4. Short-term docosapentaenoic acid (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats.
Kaur G; Begg DP; Barr D; Garg M; Cameron-Smith D; Sinclair AJ
Br J Nutr; 2010 Jan; 103(1):32-7. PubMed ID: 19650956
[TBL] [Abstract][Full Text] [Related]
5. Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study.
Guo XF; Tong WF; Ruan Y; Sinclair AJ; Li D
Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102033. PubMed ID: 31740197
[TBL] [Abstract][Full Text] [Related]
6. Orally administered [¹⁴C]DPA and [¹⁴C]DHA are metabolised differently to [¹⁴C]EPA in rats.
Kaur G; Molero JC; Weisinger HS; Sinclair AJ
Br J Nutr; 2013 Feb; 109(3):441-8. PubMed ID: 22578196
[TBL] [Abstract][Full Text] [Related]
7. Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans.
Linderborg KM; Kaur G; Miller E; Meikle PJ; Larsen AE; Weir JM; Nuora A; Barlow CK; Kallio HP; Cameron-Smith D; Sinclair AJ
Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):313-9. PubMed ID: 23433939
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the bioavailability of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in the rat.
Ghasemi Fard S; Linderborg KM; Turchini GM; Sinclair AJ
Prostaglandins Leukot Essent Fatty Acids; 2014 Jan; 90(1):23-6. PubMed ID: 24238887
[TBL] [Abstract][Full Text] [Related]
9. A short-term n-3 DPA supplementation study in humans.
Miller E; Kaur G; Larsen A; Loh SP; Linderborg K; Weisinger HS; Turchini GM; Cameron-Smith D; Sinclair AJ
Eur J Nutr; 2013 Apr; 52(3):895-904. PubMed ID: 22729967
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of dietary n-3 docosapentaenoic acid (DPA), DHA and EPA on plasma lipid parameters, oxidative status and fatty acid tissue composition.
Drouin G; Catheline D; Guillocheau E; Gueret P; Baudry C; Le Ruyet P; Rioux V; Legrand P
J Nutr Biochem; 2019 Jan; 63():186-196. PubMed ID: 30412907
[TBL] [Abstract][Full Text] [Related]
11. Membrane Disordering by Eicosapentaenoic Acid in B Lymphomas Is Reduced by Elongation to Docosapentaenoic Acid as Revealed with Solid-State Nuclear Magnetic Resonance Spectroscopy of Model Membranes.
Harris M; Kinnun JJ; Kosaraju R; Leng X; Wassall SR; Shaikh SR
J Nutr; 2016 Jul; 146(7):1283-9. PubMed ID: 27306897
[TBL] [Abstract][Full Text] [Related]
12. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
[TBL] [Abstract][Full Text] [Related]
13. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects.
Conquer JA; Cheryk LA; Chan E; Gentry PA; Holub BJ
Thromb Res; 1999 Nov; 96(3):239-50. PubMed ID: 10588467
[TBL] [Abstract][Full Text] [Related]
14. n-3 Docosapentaenoic Acid Intake and Relationship with Plasma Long-Chain n-3 Fatty Acid Concentrations in the United States: NHANES 2003-2014.
Richter CK; Bisselou KS; Nordgren TM; Smith L; Appiah AK; Hein N; Anderson-Berry A; Kris-Etherton P; Hanson C; Skulas-Ray AC
Lipids; 2019 Apr; 54(4):221-230. PubMed ID: 31025717
[TBL] [Abstract][Full Text] [Related]
15. Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina.
Philbrick DJ; Mahadevappa VG; Ackman RG; Holub BJ
J Nutr; 1987 Oct; 117(10):1663-70. PubMed ID: 2822876
[TBL] [Abstract][Full Text] [Related]
16. Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells.
Alessandri JM; Extier A; Langelier B; Perruchot MH; Heberden C; Guesnet P; Lavialle M
Lipids; 2008 Jan; 43(1):19-28. PubMed ID: 17912567
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.
Willumsen N; Vaagenes H; Lie O; Rustan AC; Berge RK
Lipids; 1996 Jun; 31(6):579-92. PubMed ID: 8784738
[TBL] [Abstract][Full Text] [Related]
18. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men.
Hussein N; Ah-Sing E; Wilkinson P; Leach C; Griffin BA; Millward DJ
J Lipid Res; 2005 Feb; 46(2):269-80. PubMed ID: 15576848
[TBL] [Abstract][Full Text] [Related]
19. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis.
Gregory MK; Gibson RA; Cook-Johnson RJ; Cleland LG; James MJ
PLoS One; 2011; 6(12):e29662. PubMed ID: 22216341
[TBL] [Abstract][Full Text] [Related]
20. Accretion of Dietary Docosahexaenoic Acid in Mouse Tissues Did Not Differ between Its Purified Phospholipid and Triacylglycerol Forms.
Adkins Y; Laugero KD; Mackey B; Kelley DS
Lipids; 2019 Jan; 54(1):25-37. PubMed ID: 30697752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
